Smitha V. Bava
Impact in
- Molecular Medicine top 2%
- Curcumin's Biomedical Applications
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
Papers in
-
- Cell death mechanisms and regulation 3
- Genomics, phytochemicals, and oxidative stress 2
- Retinoids in leukemia and cellular processes 2
-
- Synthesis and biological activity 3
- Quinazolinone synthesis and applications 2
- Co-authors
- Ruby John Anto (13 shared papers)Arun Kumar T. Thulasidasan (5 shared papers)Easwaran Sreekumar (1 shared paper)Ayswaria Deepti (1 shared paper)Devarajan Karunagaran (1 shared paper)S. Asha Nair (1 shared paper)Vino T. Cheriyan (3 shared papers)E. V. Soniya (1 shared paper)
- Journals
- Frontiers in Oncology (2 papers)Journal of Cellular and Molecular Medicine (1 paper)Cell Death Discovery (1 paper)Cell Proliferation (1 paper)The International Journal of Biochemistry & Cell Biology (1 paper)
- Partner nations
- IndiaIsraelUnited States
In The Last Decade
Smitha V. Bava
15 papers receiving 701 citations
Peers
Comparison fields: 5 of 79
- Molecular Medicine 239
- Toxicology 49
- Pharmacology 115
- Biochemistry 43
- Molecular Biology 444
Countries citing papers authored by Smitha V. Bava
This map shows the geographic impact of Smitha V. Bava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Smitha V. Bava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Smitha V. Bava more than expected).
Fields of papers citing papers by Smitha V. Bava
This network shows the impact of papers produced by Smitha V. Bava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Smitha V. Bava. The network helps show where Smitha V. Bava may publish in the future.
Co-authors
The 25 scholars most cited alongside Smitha V. Bava, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 190 | |
| 2 | 2011 | 136 | |
| 3 | 2014 | 113 | |
| 4 | 2010 | 74 | |
| 5 | 2010 | 50 | |
| 6 | 2009 | 45 | |
| 7 | 2019 | 34 | |
| 8 | 2015 | 22 | |
| 9 | 2021 | 15 | |
| 10 | 2016 | 13 | |
| 11 | 2021 | 11 | |
| 12 | 2022 | 8 | |
| 13 | 2022 | 8 | |
| 14 | 2025 | 3 | |
| 15 | 2023 | 2 |
About Smitha V. Bava
Smitha V. Bava is a scholar working on Molecular Biology, Organic Chemistry, Molecular Medicine, Cancer Research and Toxicology, having authored 15 papers that have together received 724 indexed citations. Recurring topics across this work include Curcumin's Biomedical Applications (5 papers), Bioactive Compounds and Antitumor Agents (4 papers), Synthesis and biological activity (3 papers), Cell death mechanisms and regulation (3 papers), NF-κB Signaling Pathways (3 papers), Quinazolinone synthesis and applications (2 papers), Genomics, phytochemicals, and oxidative stress (2 papers) and Retinoids in leukemia and cellular processes (2 papers). The work is most often cited by research in Molecular Medicine (239 citations), Toxicology (49 citations), Pharmacology (115 citations), Biochemistry (43 citations) and Molecular Biology (444 citations). Smitha V. Bava has collaborated with scholars based in India, Israel and United States. Frequent co-authors include Ruby John Anto, Arun Kumar T. Thulasidasan, Easwaran Sreekumar, Ayswaria Deepti, Devarajan Karunagaran, S. Asha Nair, Vino T. Cheriyan, E. V. Soniya, Lekshmi R. Nath and Vineshkumar Thidil Puliyappadamba. Their work appears in journals such as Frontiers in Oncology, Journal of Cellular and Molecular Medicine, Cell Death Discovery, Cell Proliferation and The International Journal of Biochemistry & Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.